CT Scans in Treating Patients With Stage I Testicular Cancer After Undergoing Orchiectomy
NCT00003420 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900
Last updated 2013-12-04
Summary
RATIONALE: Imaging procedures such as CT scans help the doctor in detecting cancer or the recurrence of cancer. Increasing the number of times a CT scan is given may improve the ability to detect stage I testicular cancer.
PURPOSE: Randomized clinical trial to determine if there is a different result from two different schedules of CT scans in treating patients with stage I testicular cancer after undergoing orchiectomy.
Conditions
- Testicular Germ Cell Tumor
Interventions
- PROCEDURE
-
computed tomography
Sponsors & Collaborators
- lead OTHER_GOV
Principal Investigators
-
Gordon J.S. Rustin, MD · Mount Vernon Cancer Centre at Mount Vernon Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-07-31
- Completion
- 2010-04-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
NCT03946007 ·Status: COMPLETED
-
Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma
NCT03034395 ·Status: COMPLETED ·Phase: NA
-
Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides
NCT01073267 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma
NCT01614301 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
NCT00003747 ·Status: UNKNOWN ·Phase: PHASE1
-
Understanding and Anticipating Therapeutic Response And Immuno-meDIated Adverse Events in Anti-cancer Immune-checkpoint Inhibition: a Tissue Biopsy Based imaGing Study
NCT05921123 ·Status: RECRUITING
-
Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides
NCT03789864 ·Status: TERMINATED ·Phase: NA
-
QUEST: QUality of Life and Experiences of Sarcoma Trajectories
NCT03441906 ·Status: UNKNOWN
-
The Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of Melanoma
NCT04357509 ·Status: UNKNOWN ·Phase: PHASE1
-
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00002669 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic Melanoma
NCT01376713 ·Status: COMPLETED ·Phase: PHASE2
-
A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX
NCT02383901 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00003346 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Families With Melanoma
NCT00445783 ·Status: UNKNOWN
-
Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma
NCT04274816 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
NCT00057616 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Metastatic Ocular Melanoma
NCT00168870 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma
NCT02235701 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study of UCN-01 in Metastatic Melanoma
NCT00072189 ·Status: TERMINATED ·Phase: PHASE2
-
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
NCT06008106 ·Status: RECRUITING ·Phase: PHASE3
-
Taxoprexin® Treatment for Advanced Eye Melanoma
NCT00244816 ·Status: COMPLETED ·Phase: PHASE2
-
Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers
NCT00432471 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma
NCT05827770 ·Status: UNKNOWN ·Phase: PHASE2
-
CCI-779 in Treating Patients With Metastatic Melanoma
NCT00022464 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases
NCT02336763 ·Status: TERMINATED ·Phase: NA